(PharmaNewsWire.Com, March 03, 2017 ) Subtitle: The Combination Therapies In Aesthetics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Combination Therapies in Aesthetics Market: Drivers & Restraints
The demand for combination treatments in aesthetics is rapidly growing as a result of early onset of aging which is driving demand for age-defying treatments. According to the World Population Report 2015 published by the United Nations, the global population is ageing at 1.18% per annum. Each year, approximately 83 million people are reaching the age group over 60 years per year. In addition changing demand patterns for less painful treatments by consumers is increasing the demand for combination therapies over the forecast period. On the other hand increasing demand for clinically-evidenced ingredients is boosting surgico-medical cosmetic procedures. In this regard, the American Society of Plastic Surgeons (ASPS) noted that 15.6 Mn cosmetic procedures were performed in the U.S. in 2014. Wider array of cosmetic treatment options provided by various drug and device makers is expected to fuel growth for combination therapies in aesthetics market globally.
Combination therapies can sometimes lead to adverse reactions impacting overall appearance of an individual undergoing therapy. Also high cost per procedure deter customers from repeated visits thus impacting the growth of the market in economically unstable countries for combination therapies in the near future.
Combination Therapies in Aesthetics Market: Region-wise Outlook
On the basis of region presence, combination therapies in aesthetics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia pacific excluding Japan, Japan, and Middle East and Africa. North America and Europe are the biggest markets for the combination therapies in aesthetics market. North America market is expected to continue to dominate over the next few years due to higher number of U.S. FDA approvals for botulinum products in the region. Meanwhile, it is harder to get Health Canada approval. Asia Pacific market is comparatively smaller and less penetrated than other regional markets, but also represents providers the fastest potential opportunity due to rising patient awareness for various therapeutic options and increasing accessibility to these procedures. Combination treatments such wrinkle lifting plus volume restoring are gaining popularity in this region. Healthy economic growth and disposable income levels in Brunei, Cambodia, Indonesia, Laos, Malaysia, Philippines, Singapore, Thailand, and Vietnam contribute largely to increasing demand for facial injectable products.
Combination Therapies in Aesthetics Market: Key Players
Some of the key market players in the combination therapies in aesthetics market are Merz Pharmaceuticals, Lumenis, Biopolymer GmbH &Co KG, Revance Therapeutics, Inc.,Mentor Worldwide LLC, Alma Lasers, Anika Therapeutics, Inc., Contura International A/S, Cynosure, Inc., Fibrocell, Inc., Gal derma S/A and others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
